As a trusted extension of a drug developer’s team, contract research organizations (CROs) have the capacity to complete a range of day-to-day research activities that are either not possible or too expensive to achieve in-house.
With Thermo Fisher Scientific’s PPD Biotech solutions, we bring you end-to-end capabilities, economies of scale, and greater clinical trial reliability and quality, while simplifying your drug development journey.
We intentionally built a model to better serve small- to mid-sized biotech and pharma companies by making the line between internal and outsourced teams indistinguishable.
Diverse patient populations in clinical trials ensure that safe and effective therapies are brought to market. To meet your patient diversity goals and regulatory requirements, we recommend partnering with a CRO solutions provider that has a demonstrated history of implementing comprehensive diversity plans.
Our FSP models increase flexibility and provide access to the exact expertise your project needs, when you need it, in just the right amount.
Let us help you advance your next drug development project — whether you need to fill small gaps in services or support large-scale programs with dedicated capacity management across functions.
Chris Seaton, Associate Director,
Business Development
Learn more about Chris >
- Global experience supporting biotech clients from early development consulting through Phases II-IV clinical development
- 20+ years of experience building relationships through a collaborative approach to creating fit-for-purpose solutions
- Committed to delivering for our clients and the patients their treatments will help
Paul Roberts, Ph.D., Senior Director,
Biotech Portfolio Lead
Learn more about Paul >
- 18+ years of project and clinical management experience in clinical research; joined PPD in 2012
- Global experience across all trial phases
- Therapeutic experience in Oncology, Hematology, Infectious Disease, Musculoskeletal, Neurology, Respiratory, NHV, Genitourinary, and Metabolic trials
- SME in Early Phase Oncology patient trials and in Clinical Imaging
- Ph.D. in Cell and Molecular Biology
Danko Dominis, M.D., Ph.D.
Regional Medical Officer
Learn more about Danko >
- 20+ years of experience in the clinical (medical and research) and pharmaceutical industries
- CRO management roles in NA, EMEA, and APAC with medical, strategic, and commercial responsibilities
- Experience in Rare Diseases, Oncology, Respiratory, Women’s Health, and Endocrinology
- Specialty medical training in Obstetrics & Gynecology, Ph.D. thesis in Endocrinology
Meg Turner
Regional Commercial Lead - Biotech
Learn more about Meg >
- 18+ years in the healthcare, clinical research and pharmaceutical industries
- Global experience supporting clients in Phases II-IV
- Commercial leadership in clinical development
- Business operations throughout all phases of development
JP Lewis
Account Development Lead
Learn more about JP >
- 10+ years of business-to-business, customer service-oriented experience
- Priority on cultivating and maintaining relationships based on mutual trust and understanding
- Focus on staying informed on industry trends and developments to best align PPD’s capability with client needs
- Strong ability to collaborate internally to address any potential client concerns